Resources Contact Us Home
Regulatory T cells and their use in immunotherapy and suppression of autoimmune responses

Image Number 17 for United States Patent #8129185.

Based upon a strong correlation between regulator T cells (Treg cells) and suppressing or preventing a cytotoxic T cell response, provided are methods for the production of ex vivo activated and culture-expanded isolated CD4.sup.+CD25.sup.+ suppressor Treg cells for the prevention or suppression of immune reactions in a host, particularly in a human host, and including autoimmune responses. The resulting ex vivo culture-expanded Treg cells provide a sufficient amount of otherwise low numbers of such cells, having long term suppressor capability to permit therapeutic uses, including the preventing, suppressing, blocking or inhibiting the rejection of transplanted tissue in a human or other animal host, or protecting against graft vs host disease. Also provided are therapeutic and immunosuppressive methods utilizing the ex vivo culture-expanded Treg cells for human treatment, and high efficiency methods for research use.

  Recently Added Patents
Multiple secure elements in mobile electronic device with near field communication capability
Single-wavelength correction method for luminescent homogeneous biological assay
Intake parameter-calculating device for internal combustion engine and method of calculating intake parameter
Tool box
Interactivity model for shared feedback on mobile devices
Systems and methods for synchronizing and controlling multiple image sensors
  Randomly Featured Patents
Method for making matt diffusion patterns
Bondwire utilized for coulomb counting and safety circuits
Efficiently collecting transaction-separated metrics in a distributed enviroment
Rotary drilling head
Mounting of electronic microcomponents on a support
Process for producing, in particular, two-part surgical instruments
Biotechnological purification of soil and water containing heavy metals
Spent cigarette repository
Seat lifter with ratchet-type lever mechanism
Integrated circuit architectures with heterogeneous high-speed serial interface circuitry